Alcami Strengthens Global Presence with Tjoapack Acquisition to Enhance CDMO Solutions

Alcami Completes Acquisition of Tjoapack

Alcami Corporation, a prominent U.S.-based contract development and manufacturing organization (CDMO), has officially completed the acquisition of Tjoapack, a significant player in the global contract packaging sector. This strategic move expands Alcami's operational footprint and enhances its capabilities in both the U.S. and Europe, ultimately benefiting the pharmaceutical and biotech industries.

A Strategic Expansion

Located in Wilmington, North Carolina, Alcami's acquisition of Tjoapack marks a significant milestone in its commitment to growth. Tjoapack, founded in 1989 and headquartered in the Netherlands, adds robust packaging facilities located in both the U.S. and Europe, bringing over 1,400 skilled professionals into the combined organization. This merger propels Alcami's total operational space to exceed 1 million square feet, thereby significantly boosting its capacity to produce over 80 commercial pharmaceutical products globally.

Leadership and Integration

With these changes, Alcami's CEO and Chairman, Patrick Walsh, will also take on the CEO role for the unified entities. This leadership consolidation is aimed at streamlining the integration process and maximizing the combined resources of both organizations. The two companies are currently working on advancing integration efforts to optimize their end-to-end CDMO capabilities.

Customers of both Alcami and Tjoapack can expect continuity in service across all sites during this integration phase. Moreover, Tjoapack clients will gain access to Alcami's extensive portfolio, which includes drug product manufacturing, comprehensive laboratory services, and secure pharmaceutical storage. On the other hand, Alcami’s existing clientele will benefit from enhanced packaging scale, greater supply chain redundancy, and improved access to market support, including Qualified Person (QP) release services in Europe.

Future Perspectives

Patrick Walsh expressed optimism about the acquisition, stating, "This acquisition represents a meaningful step forward in Alcami's long-term growth strategy to provide integrated global solutions for our clients." He emphasized the welcoming of the Tjoapack team and anticipated unlocking the full potential of their combined capabilities.

About the Companies

Alcami Corporation has over 45 years of expertise in advancing pharmaceuticals and biologics from development to delivery. Its services range from fully integrated lab services to primary and secondary packaging and storage solutions adhering to cGMP compliance. Alcami is backed by private equity firms such as GHO Capital, The Vistria Group, and Ampersand Capital Partners.

Meanwhile, Tjoapack is recognized for its compliance with stringent pharmaceutical packaging regulations and operates GMP-compliant facilities across key locations in Europe and the U.S., including Etten-Leur and Clinton, Tennessee. As part of Alcami, Tjoapack is poised to elevate its service offerings even further in the coming years.

Conclusion

The merger of Alcami and Tjoapack not only signifies a strategic enhancement of their operational capabilities but also reaffirms their shared commitment to delivering comprehensive and integrated solutions for their pharmaceutical clients worldwide. With the combined strength of both companies, they are well-positioned to meet the evolving demands of the biotech and pharmaceutical landscape effectively.